Home » Topics » Regulatory » Patents

Patents
RSS

2,4-Diaminopyrimidines claimed as imaging agents, potentially useful in psychotic disorders

Feb. 2, 1998

Synaptic develops selective human alpha1A-receptor antagonists

Feb. 2, 1998

Roche discloses inhibitors of bacterial dihydrofolate reductase

Feb. 2, 1998

Vitamin D3 analogues from Roche for skin, neoplastic diseases

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

New antifungals reported by J&J subsidiary

Jan. 30, 1998

Vitamin D analogues disclosed by Roche for hyperproliferative disorders

Jan. 30, 1998

Diosmetin derivatives for vascular disorders prepared at ADIR

Jan. 30, 1998

Novel chemokine identified and characterized at Millennium

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...